Diality has recently announced that it has joined Kidney Care Partners, the USAs leading kidney care multi-stakeholder coalition that represents patient advocates, physician organisations, health professional groups, dialysis providers, researchers, and manufacturers.
Diality is one of several members of Kidney Care Partners focused on innovation within kidney care, and the first pre-revenue medical device manufacturer among the new member organisations. Diality recently received 510(k) clearance for the Moda-flx haemodialysis system from the US Food and Drug Administration (FDA).
Dan Guthrie, chief business officer at Diality, shared a statement via press release, stating: “Diality is proud to become a member of an organization like Kidney Care Partners. Kidney Care Partners’ dedication to patient-centred care and innovation within kidney care is perfectly aligned with Diality’s mission of improving lives impacted by kidney disease. We look forward to contributing to Kidney Care Partners’ legislative agenda.”
The chair of Kidney Care Partners, Mahesh Krishnan, also commented on the Diality becoming the newest member of the partnership, saying: “Kidney Care Partners is thrilled to welcome Diality, a haemodialysis innovator who brings an important voice to our coalition. Together, we look forward to advancing initiatives that promote innovation and benefit patients across the kidney disease continuum.”
